John Schmid, CFO at Auspex Pharma, holds 57.64K shares in Design Therapeutics (Ticker: DSGN), holds 74.16K shares in Xeris Pharmaceuticals (Ticker: XERS), holds 39.30K shares in Poseida Therapeutics (Ticker: PSTX). Most recently, John Schmid Bought ― shares of Design Therapeutics on Mar 25, 2024 for an estimated value of 99.66K.